e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?
Daniel H.L. Lemmers, Mohammed Abu Hilal, Claudio Bnà, Chiara Prezioso, Erika Cavallo, Niccolò Nencini, Serena Crisci, Federica Fusina, Giuseppe Natalini
Source:
ERJ Open Res, 6 (4) 00385-2020; 10.1183/23120541.00385-2020
Journal Issue:
October
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Daniel H.L. Lemmers, Mohammed Abu Hilal, Claudio Bnà, Chiara Prezioso, Erika Cavallo, Niccolò Nencini, Serena Crisci, Federica Fusina, Giuseppe Natalini. Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?. ERJ Open Res, 6 (4) 00385-2020; 10.1183/23120541.00385-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Subcutaneous emphysema, pneumomediastinum and epidural emphysema in a child due to foreign body aspiration mimicking croup syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 493s
Year: 2006
²Nonobstructive² emphysema of the lung
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007
Fatal pneumomediastinum in COPD and interstitial lung fibrosis associated with use of non invasive mechanical ventilation
Source: Annual Congress 2009 - New trends in noninvasive ventilation for chronic respiratory failure
Year: 2009
Approach to the pneumomediastinum with massive subcutaneus emphysema: cervical mediastinotomy
Source: Eur Respir J 2004; 24: Suppl. 48, 175s
Year: 2004
Interstitial lung disease-related pneumomediastinum in COVID-19 patients
Source: ERJ Open Res, 7 (1) 00014-2021; 10.1183/23120541.00014-2021
Year: 2021
Bronchopleural fistula and pneumothorax following lung volume reduction coil treatment in severe emphysema: A case report
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Managing bronchiectasis and other lung complications
Source: School Course 2013 - Primary ciliary dyskinesia: sharing knowledge and experience across Europe
Year: 2013
The chance of developing lung cancers are more in combined pulmonary fibrosis & emphysema than emphysema alone
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Fluid-containing emphysematous bullae: a spectrum of illness
Source: Eur Respir J 2008; 32: 303-306
Year: 2008
Spontaneous pneumomedistinum & subcutaneous emphysema in idiopathic pulmonary fibrosis (IPF) with bronchial wall leak
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Lung volume reduction for severe emphysema: do we need a scalpel or a scope?
Source: Eur Respir Rev 2010 19: 242-247
Year: 2010
Treatment of combined pulmonary fibrosis and emphysema
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Acute exacerbation in combined pulmonary fibrosis and emphysema (CPFE): what special features?
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020
Combined pulmonary fibrosis and emphysema: a high-pressure situation
Source: Eur Respir J 2010; 35: 9-11
Year: 2010
Combined pulmonary fibrosis and emphysema: A distinct entity?
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
The causes of hemoptysis and lung hemorrhage in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Bronchoscopic lung volume reduction for emphysema: where next?
Source: Eur Respir J 2012; 39: 1287-1289
Year: 2012
Bronchoscopic lung volume reduction interventions for severe emphysema
Source: International Congress 2016 – Vitamin D and asthma prevention, COPD screening, and bronchoscopic lung volume reduction in emphysema
Year: 2016
Bilateral giant bullae... always a surgical case?
Source: Annual Congress 2007 - Interventional Pulmonology Grand Round: an interactive session
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept